(Q43259363)

17 November 2017

title

FDG PET as a prognostic predictor in the early post-therapeutic evaluation for unresectable hepatocellular carcinoma (English)

1 reference

17 November 2017

13

Shinji Uemoto

1 reference

17 November 2017

2

Etsuro Hatano

1 reference

17 November 2017

9

Kaori Togashi

1 reference

17 November 2017

5

Yuji Nakamoto

1 reference

17 November 2017

Tatsuya Higashi

1

1 reference

17 November 2017

Iwao Ikai

3

1 reference

17 November 2017

Ryuichi Nishii

4

1 reference

17 November 2017

Koichi Ishizu

6

1 reference

17 November 2017

Tsuyoshi Suga

7

1 reference

17 November 2017

Hidekazu Kawashima

8

1 reference

17 November 2017

Satoru Seo

10

1 reference

17 November 2017

Koji Kitamura

11

1 reference

17 November 2017

Yasutsugu Takada

12

1 reference

17 November 2017

publication date

17 October 2009

1 reference

17 November 2017

number of pages

15

1 reference

European Journal of Nuclear Medicine and Molecular Imaging

inferred from page(s)

published in

1 reference

17 November 2017

volume

37

1 reference

17 November 2017

issue

3

1 reference

17 November 2017

page(s)

468-482

1 reference

Estimates of the worldwide mortality from 25 cancers in 1990.

17 November 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00259-009-1284-9

Limited value of 18F-2-deoxyglucose positron emission tomography to detect hepatocellular carcinoma in hepatitis B virus carriers

21 January 2018

1 reference

12 December 2020

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

1 reference

12 December 2020

Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis

1 reference

12 December 2020

Prognosis of hepatocellular carcinoma: the BCLC staging classification

1 reference

12 December 2020

Usefulness of positron emission tomography with fluorine-18-fluorodeoxyglucose for predicting outcome in patients with hepatocellular carcinoma

1 reference

12 December 2020

Clinicopathological study on combination therapy consisting of arterial infusion of lipiodol-dissolved SMANCS and transcatheter arterial embolization for hepatocellular carcinoma

1 reference

12 December 2020

In vivo assessment of glucose metabolism in hepatocellular carcinoma with FDG-PET

1 reference

12 December 2020

Positron emission tomography scanning in the evaluation of hepatocellular carcinoma

1 reference

12 December 2020

Staging Hepatocellular Carcinoma by a Novel Scoring System (BALAD Score) Based on Serum Markers

1 reference

12 December 2020

Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations. European Organization for Research and Treatment of Cancer (EORTC) PET Study Group

1 reference

12 December 2020

Management of hepatocellular carcinoma

1 reference

12 December 2020

Chemoembolization of hepatocellular carcinoma: results of a metaanalysis

1 reference

12 December 2020

Pathology and pathogenesis of hepatocellular carcinoma.

1 reference

12 December 2020

18F-FDG PET is an early predictor of pathologic tumor response to preoperative radiochemotherapy in locally advanced rectal cancer.

1 reference

12 December 2020

Evaluation of liver tumors using fluorine-18-fluorodeoxyglucose PET: characterization of tumor and assessment of effect of treatment

1 reference

12 December 2020

Limited value of fluorine-18-fluorodeoxyglucose PET for the differential diagnosis of focal liver lesions in patients with chronic hepatitis C virus infection.

1 reference

12 December 2020

Lens culinaris agglutinin-reactive alpha-fetoprotein and protein induced by vitamin K absence II are potential indicators of a poor prognosis: a histopathological study of surgically resected hepatocellular carcinoma

1 reference

12 December 2020

Hepatocellular carcinoma: is current therapy really altering outcome?

1 reference

12 December 2020

Sorafenib in advanced hepatocellular carcinoma

1 reference

12 December 2020

Use of PET for monitoring cancer therapy and for predicting outcome

1 reference

12 December 2020

2-[18F]fluoro-2-deoxyglucose positron-emission tomography in staging, response evaluation, and treatment planning of lymphomas

1 reference

12 December 2020

Factors predictive of 5-year survival after transarterial chemoembolization for inoperable hepatocellular carcinoma.

1 reference

12 December 2020

Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation

1 reference

12 December 2020

Consensus recommendations for the use of 18F-FDG PET as an indicator of therapeutic response in patients in National Cancer Institute Trials.

1 reference

12 December 2020

Fluorine-18 FDG positron emission tomography for imaging of hepatocellular carcinoma

1 reference

12 December 2020

Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy.

1 reference

12 December 2020

Multicentre randomised phase III trial comparing Tamoxifen alone or with Transarterial Lipiodol Chemoembolisation for unresectable hepatocellular carcinoma in cirrhotic patients (Fédération Francophone de Cancérologie Digestive 9402).

1 reference

12 December 2020

Evaluation of benign vs malignant hepatic lesions with positron emission tomography

1 reference

12 December 2020

The use of 18F-FDG PET/CT in colorectal liver metastases--comparison with CT and liver MRI.

1 reference

12 December 2020

Fluorine-18 fluorodeoxyglucose positron emission tomography predicts tumor differentiation, P-glycoprotein expression, and outcome after resection in hepatocellular carcinoma

1 reference

12 December 2020

Value of fluorine-18-FDG-PET to monitor hepatocellular carcinoma after interventional therapy

1 reference

12 December 2020

PET and PET-CT for evaluation of colorectal carcinoma

1 reference

12 December 2020

Prognostic value of positron emission tomography in the evaluation of post-treatment residual mass in patients with Hodgkin's disease and non-Hodgkin's lymphoma

1 reference

12 December 2020

Preoperative positron emission tomography with fluorine-18-fluorodeoxyglucose is predictive of prognosis in patients with hepatocellular carcinoma after resection

1 reference

12 December 2020

Monitoring of early response to neoadjuvant chemotherapy in stage II and III breast cancer by [18F]fluorodeoxyglucose positron emission tomography.

1 reference

12 December 2020

Diagnosis of pancreatic cancer using fluorine-18 fluorodeoxyglucose positron emission tomography (FDG PET) --usefulness and limitations in "clinical reality".

1 reference

12 December 2020

Liver transplantation for hepatocellular cancer: should the current indication criteria be changed?

1 reference

12 December 2020

Radiofrequency ablation, PEIT, and TACE for hepatocellular carcinoma.

1 reference

12 December 2020

Expansion of selection criteria for patients with hepatocellular carcinoma in living donor liver transplantation

1 reference

12 December 2020

Cellular release of [18F]2-fluoro-2-deoxyglucose as a function of the glucose-6-phosphatase enzyme system.

1 reference

12 December 2020

Milan multicenter experience in liver transplantation for hepatocellular carcinoma

1 reference

12 December 2020

Early prediction of response to sunitinib after imatinib failure by 18F-fluorodeoxyglucose positron emission tomography in patients with gastrointestinal stromal tumor

1 reference

12 December 2020

10.1007/S00259-009-1284-9

Identifiers

DOI

1 reference

17 November 2017

1 reference